PharmAust Limited ECQ.F Stock
PharmAust Limited Price Chart
PharmAust Limited ECQ.F Financial and Trading Overview
| PharmAust Limited stock price | 0.09 EUR |
| Previous Close | 0.04 EUR |
| Open | 0.04 EUR |
| Bid | 0.04 EUR x 4500000 |
| Ask | 0.05 EUR x 3500000 |
| Day's Range | 0.04 - 0.04 EUR |
| 52 Week Range | 0.03 - 0.06 EUR |
| Volume | 5 EUR |
| Avg. Volume | 11.16K EUR |
| Market Cap | 14.89M EUR |
| Beta (5Y Monthly) | 0.75134 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ECQ.F Valuation Measures
| Enterprise Value | 11.41M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.612301 |
| Price/Book (mrq) | 1.6666666 |
| Enterprise Value/Revenue | 2.002 |
| Enterprise Value/EBITDA | -44.8 |
Trading Information
PharmAust Limited Stock Price History
| Beta (5Y Monthly) | 0.75134 |
| 52-Week Change | -16.12% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.06 EUR |
| 52 Week Low | 0.03 EUR |
| 50-Day Moving Average | 0.05 EUR |
| 200-Day Moving Average | 0.04 EUR |
ECQ.F Share Statistics
| Avg. Volume (3 month) | 11.16K EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 317.48M |
| Float | 208.2M |
| Short Ratio | N/A |
| % Held by Insiders | 37.02% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -8.80% |
| Operating Margin (ttm) | -7.35% |
| Gross Margin | 94.18% |
| EBITDA Margin | -4.46% |
Management Effectiveness
| Return on Assets (ttm) | -2.53% |
| Return on Equity (ttm) | -6.21% |
Income Statement
| Revenue (ttm) | 5.7M EUR |
| Revenue Per Share (ttm) | 0.02 EUR |
| Quarterly Revenue Growth (yoy) | 69.09% |
| Gross Profit (ttm) | 4.2M EUR |
| EBITDA | -254604 EUR |
| Net Income Avi to Common (ttm) | -501917 EUR |
| Diluted EPS (ttm) | -126.99 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.06M EUR |
| Total Cash Per Share (mrq) | 0.007 EUR |
| Total Debt (mrq) | 1.11M EUR |
| Total Debt/Equity (mrq) | 14.34 EUR |
| Current Ratio (mrq) | 2.882 |
| Book Value Per Share (mrq) | 0.024 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -473696 EUR |
| Levered Free Cash Flow (ttm) | -247812 EUR |
Profile of PharmAust Limited
| Country | Germany |
| State | WA |
| City | Bentley |
| Address | 5/3 Brodie Hall Drive |
| ZIP | 6102 |
| Phone | 61 8 9202 6814 |
| Website | https://www.pharmaust.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. The company has a research agreement with the Walter and Eliza Hall Institute to investigate the effects of MPL upon human T-lymphotrophic virus-1 (HTLV-1) infections in vitro. It serves drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia.
Q&A For PharmAust Limited Stock
What is a current ECQ.F stock price?
PharmAust Limited ECQ.F stock price today per share is 0.09 EUR.
How to purchase PharmAust Limited stock?
You can buy ECQ.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PharmAust Limited?
The stock symbol or ticker of PharmAust Limited is ECQ.F.
Which industry does the PharmAust Limited company belong to?
The PharmAust Limited industry is Biotechnology.
How many shares does PharmAust Limited have in circulation?
The max supply of PharmAust Limited shares is 539.71M.
What is PharmAust Limited Price to Earnings Ratio (PE Ratio)?
PharmAust Limited PE Ratio is now.
What was PharmAust Limited earnings per share over the trailing 12 months (TTM)?
PharmAust Limited EPS is -0.01 EUR over the trailing 12 months.
Which sector does the PharmAust Limited company belong to?
The PharmAust Limited sector is Healthcare.